35 results on '"Hendriks, Dirk"'
Search Results
2. Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke
3. Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals
4. Carboxypeptidase M in apoptosis, adipogenesis and cancer
5. Effect of Statin Therapy on the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients With Hyperlipidemia: A Proof-of-concept Observational Study
6. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients
7. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
8. Carboxypeptidase M: Multiple alliances and unknown partners
9. A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation
10. Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysis
11. Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate
12. Properties of recombinant human plasma procarboxypeptidase U produced in mammalian and insect cells
13. Lower Baseline Plasma Cortisol and Prolactin together with Increased Body Temperature and Higher mCPP-Induced Cortisol Responses in Men with Pedophilia
14. Proteolytic activation of purified human procarboxypeptidase U
15. Chapter 295 - Carboxypeptidase U
16. Measurement of carboxypeptidase U (active thrombin-activatable fibrinolysis inhibitor) in plasma: Challenges overcome by a novel selective assay
17. Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma
18. Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages
19. Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development
20. The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays
21. 242 - Carboxypeptidase U
22. Major carboxypeptidase N deficiency
23. Synthesis of peptidyl acetals as inhibitors of prolyl endopeptidase
24. Effects of psychological stress on serum immunoglobulin, complement and acute phase protein concentrations in normal volunteers
25. Purification and characterization of a new arginine carboxypeptidase in human serum
26. Dipeptide-derived diphenyl phosphonate esters: mechanism-based inhibitors of dipeptidyl peptidase IV
27. Influence of academic examination stress on hematological measurements in subjectively healthy volunteers
28. Exopeptidases in human platelets: an indication for proteolytic modulation of biologically active peptides
29. Identification of the carboxypeptidase responsible for the post-synthetic modification of creatine kinase in human serum
30. Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes
31. Kininase activity in human platelets: Cleavage of the Arg 1-Pro 2 bond of bradykinin by aminopeptidase P
32. Carboxypeptidase N: Colorimetric assay using a new substrate
33. Colorimetric assay for carboxypeptidase N in serum
34. 145 Procarboxypeptidase u is expressed in human liver
35. The Gene for Human Carboxypeptidase U (CPU)— A Proposed Novel Regulator of Plasminogen Activation— Maps to 13q14.11
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.